annual EBITDA:
-$157.24M-$54.76M(-53.43%)Summary
- As of today (June 17, 2025), GPCR annual EBITDA is -$157.24 million, with the most recent change of -$54.76 million (-53.43%) on December 31, 2024.
- During the last 3 years, GPCR annual EBITDA has fallen by -$119.61 million (-317.91%).
- GPCR annual EBITDA is now -888.53% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
GPCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$56.04M-$9.25M(-19.77%)Summary
- As of today (June 17, 2025), GPCR quarterly EBITDA is -$56.04 million, with the most recent change of -$9.25 million (-19.77%) on March 31, 2025.
- Over the past year, GPCR quarterly EBITDA has dropped by -$24.24 million (-76.26%).
- GPCR quarterly EBITDA is now -344.14% below its all-time high of -$12.62 million, reached on September 30, 2022.
Performance
GPCR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$181.48M-$24.24M(-15.42%)Summary
- As of today (June 17, 2025), GPCR TTM EBITDA is -$181.48 million, with the most recent change of -$24.24 million (-15.42%) on March 31, 2025.
- Over the past year, GPCR TTM EBITDA has dropped by -$66.79 million (-58.23%).
- GPCR TTM EBITDA is now -1274.02% below its all-time high of -$13.21 million, reached on December 1, 2021.
Performance
GPCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GPCR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.4% | -76.3% | -58.2% |
| 3 y3 years | -317.9% | -335.0% | -595.6% |
| 5 y5 years | -888.5% | -324.3% | -1274.0% |
GPCR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -317.9% | at low | -344.1% | at low | -353.8% | at low |
| 5 y | 5-year | -888.5% | at low | -344.1% | at low | -1274.0% | at low |
| alltime | all time | -888.5% | at low | -344.1% | at low | -1274.0% | at low |
GPCR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$56.04M(+19.8%) | -$181.48M(+15.4%) |
| Dec 2024 | -$157.24M(+53.4%) | -$46.79M(+2.7%) | -$157.24M(+11.2%) |
| Sep 2024 | - | -$45.57M(+37.7%) | -$141.37M(+16.0%) |
| Jun 2024 | - | -$33.08M(+4.1%) | -$121.86M(+6.3%) |
| Mar 2024 | - | -$31.79M(+2.8%) | -$114.69M(+11.9%) |
| Dec 2023 | -$102.48M | -$30.92M(+18.6%) | -$102.48M(+21.4%) |
| Sep 2023 | - | -$26.07M(+0.6%) | -$84.44M(+18.9%) |
| Jun 2023 | - | -$25.91M(+32.4%) | -$70.99M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$19.58M(+52.0%) | -$58.98M(+12.8%) |
| Dec 2022 | -$52.28M(+39.0%) | -$12.88M(+2.1%) | -$52.28M(-0.6%) |
| Sep 2022 | - | -$12.62M(-9.2%) | -$52.61M(+31.5%) |
| Jun 2022 | - | -$13.90M(+7.9%) | -$39.99M(+53.3%) |
| Mar 2022 | - | -$12.88M(-2.5%) | -$26.09M(+97.5%) |
| Dec 2021 | -$37.62M(+136.5%) | - | - |
| Dec 2021 | - | -$13.21M | -$13.21M |
| Dec 2020 | -$15.91M | - | - |
FAQ
- What is Structure Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Structure Therapeutics?
- What is Structure Therapeutics annual EBITDA year-on-year change?
- What is Structure Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Structure Therapeutics?
- What is Structure Therapeutics quarterly EBITDA year-on-year change?
- What is Structure Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Structure Therapeutics?
- What is Structure Therapeutics TTM EBITDA year-on-year change?
What is Structure Therapeutics annual EBITDA?
The current annual EBITDA of GPCR is -$157.24M
What is the all time high annual EBITDA for Structure Therapeutics?
Structure Therapeutics all-time high annual EBITDA is -$15.91M
What is Structure Therapeutics annual EBITDA year-on-year change?
Over the past year, GPCR annual EBITDA has changed by -$54.76M (-53.43%)
What is Structure Therapeutics quarterly EBITDA?
The current quarterly EBITDA of GPCR is -$56.04M
What is the all time high quarterly EBITDA for Structure Therapeutics?
Structure Therapeutics all-time high quarterly EBITDA is -$12.62M
What is Structure Therapeutics quarterly EBITDA year-on-year change?
Over the past year, GPCR quarterly EBITDA has changed by -$24.24M (-76.26%)
What is Structure Therapeutics TTM EBITDA?
The current TTM EBITDA of GPCR is -$181.48M
What is the all time high TTM EBITDA for Structure Therapeutics?
Structure Therapeutics all-time high TTM EBITDA is -$13.21M
What is Structure Therapeutics TTM EBITDA year-on-year change?
Over the past year, GPCR TTM EBITDA has changed by -$66.79M (-58.23%)